Related Experiment Video
Updated: May 31, 2026
10:11
Isolation and Identification of Limbal Niche Cells
Published on: October 27, 2023
Stem cells of the human cornea.
1Inflammation and Infection Research Centre, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia. n.digirolamo@unsw.edu.au
British Medical Bulletin
|June 18, 2011
Summary
Corneal epithelial stem cells (ESCs) research is exploring alternative cell sources for treating blindness due to donor shortages. Current therapies face challenges with contamination and efficacy, prompting investigation into embryonic and fetal stem cells.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Corneal blindness affects millions globally, necessitating cell or tissue repair strategies.
- The corneal epithelial stem cell (ESC) population is crucial for maintaining corneal health and function.
- Understanding ESCs, their niche, identification, and alternatives is vital for developing effective treatments.
Purpose of the Study:
- To review the current understanding of corneal epithelial stem cells (ESCs).
- To explore alternative cell sources for corneal repair and replacement.
- To discuss controversies and future directions in corneal stem cell therapy.
Main Methods:
- Literature search using PubMed with keywords: cornea, limbal, stem cells, epithelium, stroma, endothelium.
- Analysis of existing research on corneal stem cell niches and therapies.
Main Results:
- The traditional view of a unique niche for corneal ESCs is challenged by findings of similar activity in the central cornea.
- Controversies exist regarding cell therapies, particularly contamination with xenogeneic factors.
- Donor material shortages drive the search for alternative cellular sources.
Conclusions:
- Conjunctival and oral mucosal epithelium are currently the only successful substitutes for severe corneal epithelial defects.
- Embryonic and fetal stem cells show promise but face significant ethical, legal, and scientific barriers.
- Further research is needed to overcome hurdles for routine clinical use of alternative stem cells.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...